Searched for
BIOCON BRAZIL DEAL
Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in BrazilBiocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis re...- Biocon signs 10-year Brazil supply deal for Pertuzumab breast cancer drugIn a significant move, Biocon has secured a ten-year contract in Brazil for the distribution of Pertuzumab, made possible through its colla...
- Stocks with good short-term prospects likely to manage volatility; 5 stocks with up to 32% upsideStocks with good short-term prospects are more likely to manage volatility, which is expected to intensify amid multiple geopolitical and m...
- Biocon rises 3% as co enters Brazilian generic formulation marketChief Executive Officer and Managing Director, Siddharth Mittal, Biocon Ltd, said the association with Libbs Farmaceutica will help his com...
- Biocon partners with Libbs Farmaceutica to launch generic drugs in BrazilThis partnership, which marks the entry of Biocon’s generic formulations into Latin America, builds upon a successful association with Libb...
- Given valuation today, taking some profits won't be bad: Krishna Memani, OppenheimerFundsEMs at the moment offer significantly better value because the growth outlook is more stable.
- Nifty reclaims crucial 8,150, Sensex jumps over 250 points; RIL top gainer, up 3%; Orchid Chem up 12%The S&P BSE Sensex rallied over 100 points in trade on Thursday, after the US Federal Reserve sounded more dovish than many had expected.
- Elder Pharma crashes 8% on worry about residual business; Torrent down 4%The deal is a not a good one for anybody to go in for right now, rather investors could go for a growth stocks like Lupin, Aurobindo and Bi...
- Buy Lupin, Aurobindo Pharma, Biocon in pharma space: Sonam UdasiEven Cipla is a laggard but then there is a potential there that valuations are attractive and at some point it should turnaround.
- Agila, with first class people, is a very high-quality asset: Rajiv MalikMylan has completed the acquisition of Agila Specialties division from Strides Arcolab for a total value of $1.75 billion (about Rs10,800 c...
- Pfizer in $200 million insulin deal with BioconBiocon received $200 million upfront from New York-based Pfizerwhich is re-entering the $14-billion global insulin market almost four years...
- It's Aitraaz for South Africa's MTN, Bollywood ishtyleMTN possibly first found its mention in India in the movie named Aitraaz, meaning objection! 'Unforgettable' Bachchans pics | Bollywood at ...
Load More
